Literature DB >> 15135419

Optimised expression in Escherichia coli and purification of the functional form of the Bacillus thuringiensis Cry4Aa delta-endotoxin.

Panadda Boonserm1, Walairat Pornwiroon, Gerd Katzenmeier, Sakol Panyim, Chanan Angsuthanasombat.   

Abstract

Achieving high-level expression of the Bacillus thuringiensis Cry4Aa mosquito-larvicidal protein was demonstrated. The 130-kDa Cry4Aa protoxin was overexpressed as an inclusion body in Escherichia coli under the control of the tac promoter together with the cry4Ba promoter. The solubility of the toxin inclusions in carbonate buffer, pH 10.0, was markedly enhanced at a cultivation temperature of 30 degrees C. Elimination of the tryptic cleavage site at Arg-235 in the loop between helices 5 and 6 still retained the high-level toxicity of E. coli cells expressing the Cry4Aa mutant against Aedes aegypti larvae. Trypsin digestion of the R235Q mutant protoxin produced a protease-resistant fragment of ca. 65kDa. A homogeneous product of the 65-kDa trypsin-treated R203Q protein was obtained after size-exclusion chromatography that would pave the way for the further crystallisation and X-ray crystallographic studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135419     DOI: 10.1016/j.pep.2004.02.016

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of a full-length active form of the Cry4Ba toxin from Bacillus thuringiensis.

Authors:  Niramon Thamwiriyasati; Somsri Sakdee; Phimonphan Chuankhayan; Gerd Katzenmeier; Chun Jung Chen; Chanan Angsuthanasombat
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-05-29

2.  Structure of the functional form of the mosquito larvicidal Cry4Aa toxin from Bacillus thuringiensis at a 2.8-angstrom resolution.

Authors:  Panadda Boonserm; Min Mo; Chanan Angsuthanasombat; Julien Lescar
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.